Geneva, Switzerland,21July2020 –08:00amCEST –GeNeuro(Euronext Paris: CH0308403085 –GNRO), a biopharmaceutical company focused on stopping causal factors driving the progression of neurodegenerative and autoimmune diseases such as multiple sclerosis, today announced datashowing the etiological interplay between human endogenous retroviral (HERV) proteins and the emergence of psychotic phenomenain mice
More information on : http://www.geneuro.com/data/news/2020.07.21-GeNeuro-PR-Fondamental-EN-final.pdf
